Chemoprevention of Breast Cancer with Fenretinide

ISSN： 0012-6667

Source： Drugs, Vol.61, Iss.7, 2001-01, pp. : 909-918

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

ASCO update on breast cancer chemoprevention

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 381, 2002-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

ASCO update on breast cancer chemoprevention

Inpharma, Vol. 1, Iss. 1355, 2002-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Chemoprevention of Breast Cancer: Implications for Postmenopausal Women

By Fabian C.J.

Drugs & Aging, Vol. 19, Iss. 1, 2002-01 ,pp. : 43-78

Adis International

Access to resources Recommend Favorite

Fenretinide: a prototype cancer prevention drug

By Malone Winfred Perloff Marjorie Crowell James Sigman Caroline Higley Howard

Expert Opinion on Investigational Drugs, Vol. 12, Iss. 11, 2003-11 ,pp. : 1829-1842

Informa Healthcare

Access to resources Recommend Favorite

Breast cancer chemoprevention: risk-benefit effects of the antioestrogen tamoxifen

By Brown Karen

Expert Opinion on Drug Safety, Vol. 1, Iss. 3, 2002-09 ,pp. : 253-267

Informa Healthcare

Access to resources Recommend Favorite